Cancer Gene Therapy
Studies from Y. Zhu and Co-Researchers Yield New Data on Cancer Gene Therapy
Published in Gene Therapy Weekly, June 30th, 2011
2011 JUN 30 -- New investigation results, "Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity," are detailed in a study published in Journal of Inorganic Biochemistry. "Gold(III) compounds have been examined for potential anti-cancer activity. It is proposed that the molecular targets of these compounds are thiol-containing biological molecules such as the cathepsin cysteine proteases," scientists in Langley, Canada report.
"These enzymes have been implicated in many diseases including cancer. The catalytic mechanism of the cathepsin cysteine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-06-30)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data from Shanghai Institute of Materia Medica Advance Knowledge in Gene Therapy - Small Interference RNAs (siRNAs)
Data on Small Interference RNAs (siRNAs) Reported by S. Seth and Co-Researchers - Small Interference RNAs (siRNAs)
Findings from University of Shizuoka Advance Knowledge in Small Interference RNAs (siRNAs) - Small Interference RNAs (siRNAs)
New Data from Washington State University Illuminate Research in Small Interference RNAs (siRNAs) - Lymphocytic Leukemia
New Findings Reported from Ohio State University Medical Center Describe Advances in Lymphocytic Leukemia - Gene Therapy
New Gene Therapy Data Have Been Reported by Scientists at National Heart and Lung Institute - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
